Clinical Trial Update: Hyzaar Asia HEAALTH (0954A-950) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Hyzaar for hypertension in Asia (HEAALTH 0954A-950) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Hyzaar (losartan/hydrochlorothiazide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED